PMID- 27260837 OWN - NLM STAT- MEDLINE DCOM- 20180227 LR - 20181113 IS - 1095-953X (Electronic) IS - 0969-9961 (Print) IS - 0969-9961 (Linking) VI - 94 DP - 2016 Oct TI - Cognitive deficits triggered by early life stress: The role of histone deacetylase 1. PG - 1-9 LID - S0969-9961(16)30120-6 [pii] LID - 10.1016/j.nbd.2016.05.018 [doi] AB - Studies showed that histone deacetylase (HDAC) inhibitors can reverse cognitive deficits found in neurodegenerative disorders and age-related memory decline. However, the role of HDACs in stress-induced cognitive deficits has not been investigated. In the stress-susceptible mouse strain Balb/c, early life stress triggers a persistent decrease in HDAC expression in the forebrain neocortex, including reduced expression of class I HDACs. The same mice show pronounced cognitive deficits in adulthood, namely deficits in working memory and attention set-shifting. Here we show that these mice also exhibit reduced association of HDAC1 with promotor III of the brain-derived neurotrophic factor (Bdnf) gene, and that cognitive testing leads to abnormally increased Bdnf mRNA expression. A pharmacological reduction of Bdnf-tropomyosine kinase B receptor signaling effectively reverses the cognitive deficits, indicating that enhanced transcriptional activation of the Bdnf gene contributes to their emergence. In contrast to Balb/c mice, C57Bl/6 mice only develop attention set-shifting deficits when raised by Balb/c foster mothers during the time the pups are exposed to early life stress. HDAC1 levels at Bdnf promotor III are unaltered in such C57Bl/6 mice, although they exhibit decreased levels of HDAC1 at the promotor of the early-growth response gene 2 (Egr2) and abnormally increased Egr2 mRNA expression after cognitive testing. Hence, contrary to the beneficial effects of HDAC inhibition in neurodegenerative diseases, the reduced HDAC1 levels at promotors of distinct plasticity-associated genes predispose animals exposed to early life stress to enhanced expression of these genes upon cognitive challenge, an effect that negatively influences cognitive task performance. CI - Copyright (c) 2016 Elsevier Inc. All rights reserved. FAU - Adler, Samantha M AU - Adler SM AD - Department of Psychiatry, Columbia University, New York, NY 10032, United States. FAU - Schmauss, Claudia AU - Schmauss C AD - Department of Psychiatry, Columbia University, New York, NY 10032, United States; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, United States. Electronic address: cs581@cumc.columbia.edu. LA - eng GR - R21 MH099251/MH/NIMH NIH HHS/United States PT - Journal Article DEP - 20160531 PL - United States TA - Neurobiol Dis JT - Neurobiology of disease JID - 9500169 RN - 0 (Histone Deacetylase Inhibitors) RN - EC 2.7.10.1 (Receptor, trkB) RN - EC 3.5.1.98 (Hdac1 protein, mouse) RN - EC 3.5.1.98 (Histone Deacetylase 1) SB - IM MH - Animals MH - Cognition/*physiology MH - Cognition Disorders/genetics/*physiopathology MH - Cognitive Dysfunction/genetics/*physiopathology MH - Histone Deacetylase 1/genetics/*metabolism MH - Histone Deacetylase Inhibitors/pharmacology MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Neurons/metabolism MH - Receptor, trkB/metabolism MH - Stress, Physiological/genetics/*physiology PMC - PMC4983517 MID - NIHMS793261 OTO - NOTNLM OT - Attention set-shifting OT - Bdnf promotor OT - Egr2 promotor OT - Gene expression OT - HDAC1 activity OT - Working memory COIS- CONFLICT OF INTEREST: The authors declare no competing financial interest. EDAT- 2016/06/05 06:00 MHDA- 2018/02/28 06:00 PMCR- 2017/10/01 CRDT- 2016/06/05 06:00 PHST- 2015/12/30 00:00 [received] PHST- 2016/05/13 00:00 [revised] PHST- 2016/05/30 00:00 [accepted] PHST- 2016/06/05 06:00 [entrez] PHST- 2016/06/05 06:00 [pubmed] PHST- 2018/02/28 06:00 [medline] PHST- 2017/10/01 00:00 [pmc-release] AID - S0969-9961(16)30120-6 [pii] AID - 10.1016/j.nbd.2016.05.018 [doi] PST - ppublish SO - Neurobiol Dis. 2016 Oct;94:1-9. doi: 10.1016/j.nbd.2016.05.018. Epub 2016 May 31.